Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03262389 · ClinicalTrials.gov registry record · Phase 2

Comparison of F-18 FDG and C-11 Acetate PET in Multiple Myeloma

A Phase 2 study of Multiple Myeloma, sponsored by Michael C Roarke, MD.

Completed
Registry status
Phase 2
Development phase
10
Enrollment target
1
Study location

NCT03262389: Completed Phase 2 study of Multiple Myeloma, sponsored by Michael C Roarke, MD.

NCT03262389 is a Phase 2 study of Multiple Myeloma that has completed, run by Michael C Roarke, MD. The registered enrollment target is 10 participants, below the 547-participant average among 438 other Multiple Myeloma trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03262389, a Phase 2 study of Multiple Myeloma, has completed, sponsored by Michael C Roarke, MD.

COMPLETED
Registry status
Phase 2
Development phase
10 participants
Enrollment target
1
Study location

Study Summary

Investigators are doing this study to determine which of four imaging techniques: Fludeoxyglucose Positron Emission Tomography (18 FDG PET) computerized tomography (CT), 18 FDG PET Magnetic resonance imaging (MRI), C-11 acetate PET CT, and C-11 acetate PET MRI) is the best test for finding sites of active myeloma disease.

Conditions Studied

Multiple Myeloma

Interventions

  • DRUG Fludeoxyglucose PET CT
  • DRUG Sodium Acetate C11 PET CT
  • DRUG Fludeoxyglucose PET MRI
  • DRUG Sodium Acetate C11 PET MRI

Study Locations (1)

Arizona

  • Mayo Clinic in Arizona - Scottsdale

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2017-09-19
Est. Completion 2019-11-23
Phase Phase 2

Sponsor

Michael C Roarke, MD

1 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03262389

The ClinicalTrials.gov registry entry for NCT03262389 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 547-participant average among 438 other Multiple Myeloma trials with a reported enrollment target (98% lower). The listed sponsor is Michael C Roarke, MD, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Multiple Myeloma appearing as the primary indexed condition, and to 4 interventions - of which Fludeoxyglucose PET CT is the first listed.

NCT03262389 reports 1 study location spanning 1 distinct geographic area - top geographies include Arizona.

Frequently Asked Questions

What is clinical trial NCT03262389 about?

NCT03262389 is a clinical study titled "Comparison of F-18 FDG and C-11 Acetate PET in Multiple Myeloma". Investigators are doing this study to determine which of four imaging techniques: Fludeoxyglucose Positron Emission Tomography (18 FDG PET) computerized tomography (CT), 18 FDG PET Magnetic resonance imaging (MRI), C-11 acetate PET CT, and C-11 acetate PET MRI) is the best test for finding sites of ...

What is the current status of trial NCT03262389?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 10 participants. The study started on 2017-09-19. Estimated completion is 2019-11-23.

What conditions does trial NCT03262389 study?

This clinical trial studies the following conditions: Multiple Myeloma.

What interventions are being tested in trial NCT03262389?

The interventions under investigation include: Fludeoxyglucose PET CT (DRUG), Sodium Acetate C11 PET CT (DRUG), Fludeoxyglucose PET MRI (DRUG), Sodium Acetate C11 PET MRI (DRUG).

Who is sponsoring clinical trial NCT03262389?

This trial is sponsored by Michael C Roarke, MD, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03262389 being conducted?

This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Multiple Myeloma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Multiple Myeloma

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Related

Compare this shortlist side-by-side

Read our methodology - how this data is sourced, computed, and verified.
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.